DISSOLUTION SYSTEM FOR NIFEDIPINE SUSTAINED-RELEASE FORMULATIONS

被引:11
|
作者
CHAUDHARY, RS
GANGWAL, SS
GUPTA, VK
SHAH, YN
JINDAL, KC
KHANNA, S
机构
[1] Lupin Laboratories Limited, MIDC, Chikalthana, Aurangabad
关键词
D O I
10.3109/03639049409038366
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An in-vitro system for evaluating Nifedipine sustained release formulations has been developed. Two systems were evaluated to simulate sink conditions and correlate the system with flow through dissolution system in mechanism. For the purpose of evaluation two commercial brands were studied. The acidic biphasic system was found to be good for in-vitro dissolution rate evaluation of sustained release nifedipine tablets. It can be successfully utilized for routine quality control work.
引用
收藏
页码:1267 / 1274
页数:8
相关论文
共 50 条
  • [1] DISSOLUTION SYSTEM FOR NIFEDIPINE SUSTAINED-RELEASE FORMULATIONS
    CHAUDHARY, RS
    GANGWAL, SS
    GUPTA, VK
    SHAH, YN
    JINDAL, KC
    KHANNA, S
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (15) : 1939 - 1946
  • [2] SUSTAINED-RELEASE NIFEDIPINE FORMULATIONS - MOMENT, MODELING AND SIMULATION AS PHARMACOKINETIC ANALYSIS APPROACH
    REMUNAN, C
    MRHAR, A
    PRIMOZIC, S
    KARBA, R
    VILAJATO, JL
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (02) : 187 - 202
  • [3] SUSTAINED-RELEASE OF NIFEDIPINE FROM GRANULES
    KOHRI, N
    MORI, KI
    MIYAZAKI, K
    ARITA, T
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (01) : 57 - 61
  • [4] Supramicellar solutions of sodium dodecyl sulphate as dissolution media to study the in vitro release characteristics of sustained-release formulations containing an insoluble drug: Nifedipine
    Maggi, L
    Torre, ML
    Giunchedi, P
    Conte, U
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 135 (1-2) : 73 - 79
  • [5] Sequential-injection system for drug-dissolution studies of ibuprofen tablets and sustained-release formulations
    Liu, XZ
    Fang, ZL
    [J]. ANALYTICA CHIMICA ACTA, 1998, 358 (02) : 103 - 110
  • [6] BIOAVAILABILITY OF SUSTAINED-RELEASE PROPRANOLOL FORMULATIONS
    MCAINSH, J
    BABER, NS
    HOLMES, BF
    YOUNG, J
    ELLIS, SH
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (01) : 39 - 48
  • [7] SUSTAINED-RELEASE OPHTHALMIC FORMULATIONS OF PILOCARPINE
    DESHPANDE, SG
    SHIROLKAR, S
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (03) : 197 - 200
  • [8] BIOAVAILABILITY OF SUSTAINED-RELEASE THEOPHYLLINE FORMULATIONS
    REGAZZI, MB
    RONDANELLI, R
    VIDALE, E
    CRISTIANI, D
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1983, 21 (05) : 245 - 251
  • [9] EFFECT OF FOOD ON NIFEDIPINE SUSTAINED-RELEASE PREPARATION
    UENO, K
    KAWASHIMA, S
    UEMOTO, K
    IKADA, T
    MIYAI, K
    WADA, K
    YAMAZAKI, K
    MATSUMOTO, K
    NAKATA, I
    [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (09): : 662 - 665
  • [10] AN INVITRO STUDY OF THE STEREOSELECTIVE DISSOLUTION OF (RAC)-VERAPAMIL FROM 2 SUSTAINED-RELEASE FORMULATIONS
    AUBRY, AF
    WAINER, IW
    [J]. CHIRALITY, 1993, 5 (02) : 84 - 90